Lesson plan

MDA-19

MDA-19 (also known as BZO-HEXOXIZID) is a drug that acts as a potent and selective agonist for the cannabinoid receptor CB 2 , with reasonable selectivity over the psychoactive CB 1 receptor, though with some variation between species. In animal studies it was effective for the treatment of neuropathic pain, but did not affect rat locomotor activity in that specific study. The pharmacology of MDA-19 in rat cannabinoid receptors have been demonstrated to function differently than human cannabinoid receptors with MDA-19 binding to human CB 1 receptors 6.9× higher than rat CB 1 receptors.

Back to article

Article summary

MDA-19 (also known as BZO-HEXOXIZID) is a drug that acts as a potent and selective agonist for the cannabinoid receptor CB 2 , with reasonable selectivity over the psychoactive CB 1 receptor, though with some variation between species. In animal studies it was effective for the treatment of neuropathic pain, but did not affect rat locomotor activity in that specific study. The pharmacology of MDA-19 in rat cannabinoid receptors have been demonstrated to function differently than human cannabinoid receptors with MDA-19 binding to human CB 1 receptors 6.9× higher than rat CB 1 receptors.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.